Dec 19, 2024, 06:53
Martin Guscott: Detection of somatic structural variants of circulating tumor DNA in children with solid tumors
Martin Guscott, Director of Xenon Life Sciences Ltd. Consultancy in Medical and Clinical Affairs and Vice President Medical Affairs of Resonance, shared a post on LinkedIn:
“Please join the Global Neuroblastoma Meeting on Thursday to hear from Dr Brian D Crompton on “Detection of somatic structural variants enables quantification and characterization of circulating tumor DNA in children with solid tumors”.
Attendance is free for healthcare professionals and academic researchers.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 19, 2024, 07:17
Dec 19, 2024, 02:52
Dec 19, 2024, 02:47
Dec 19, 2024, 02:43
Dec 19, 2024, 02:20